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Background: The Fontan operation is performed for surgical palliation of single ventricle physiology. This operation is usually pre-

ceded by a superior cavopulmonary connection (SCPC); lymphatic abnormalities after SCPC may be demonstrated at MRI and
prior to the Fontan operation.

Purpose: To determine if the degree of neck and thoracic lymphatic abnormalities at T2-weighted MRI in patients after superior
cavopulmonary connection (SCPC) correlated with surgical outcomes from the Fontan procedure.
Materials and Methods: Patients for whom SCPC was performed for palliation of single ventricle disease who underwent chest MRI

between July 2012 and May 2015 at a single institution were retrospectively reviewed. T2-weighted images were scored as lymphatic type 1 (little or no T2 mediastinal and supraclavicular signal) to type 4 (T2 signal into both the mediastinum and the lung
parenchyma). Fontan takedown, duration of post-Fontan hospitalization and pleural effusion, postoperative plastic bronchitis, need
for transplant, and mortality were tabulated. The relationship between lymphatic type and clinical outcomes was evaluated by using
analysis of variance (ANOVA), the Kruskal-Wallis H test, and the Fisher exact test.

Results: A total of 83 patients (mean age, 7.9 years 6 2.6) were evaluated. Among these 83 patients, 53 (64%) were classified with

type 1 or 2 lymphatic abnormalities, 17 (20%) with type 3, and 12 (16%) with type 4. The rate of failure of Fontan completion
was higher in patients with type 4 than in type 1 or 2 (54% vs 2%, respectively; P = .004). Need for cardiac transplant (one of 13
[8%]) and death (three of 13 [23%]) occurred only in type 4. Median postoperative length of stay was longer for patients with type
4 than for those with types 1 or 2 (29 days vs 9 days, respectively; P , .01).

Conclusion: Greater MRI-based severity of lymphatic abnormalities in patients prior to planned Fontan procedure was associated
with failure of Fontan completion and longer postoperative stay.
© RSNA, 2019
Online supplemental material is available for this article.

Tsurgical palliation is one of the most complex subgroup-

he spectrum of single ventricle disease and associated

ings of congenital heart disease. This growing patient population has unique needs for clinical and imaging followup due to their susceptibility to a wide range of acute and
late complications (1,2).
The total cavopulmonary connection or Fontan operation is the final planned stage of surgical palliation
for patients with single ventricle physiology and is usually preceded by a superior cavopulmonary connection
(SCPC). The lymphatic system is adversely affected
by Fontan physiology (3–6). Increased central venous
pressure, inherent in the Fontan circulation, leads to
a shift in Starling forces and increased lymphatic production, especially by the liver (7–10). The increased
central venous pressure also impedes lymphatic drainage, leading to compensatory lymphatic changes and

in some cases complications of lymphatic failure, such
as chylous effusions, plastic bronchitis, and proteinlosing enteropathy (3–6). Lymphatic abnormalities
in patients with single ventricle physiology are often
present in fetal life in association with congenital cardiovascular anomalies and demonstrate early effects
on neonatal outcomes (11). The observation of early
lymphatic abnormalities has been demonstrated with
SCPC prior to the Fontan operation (5).
Sometimes these cardiovascular and lymphatic complications can lead to the need for urgent Fontan takedown
or patient death (12–14). Multiple clinical and imaging
factors have been investigated as predictors of successful
Fontan palliation, including ventricular systolic and diastolic function, favorable pulmonary vascular resistance,
and unobstructed pulmonary vasculature (15); however,
most cases of Fontan failure are still unexplained despite
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Abbreviations
ANOVA = analysis of variance, ECMO = extracorporeal membrane
oxygenation, HLHS = hypoplastic left heart syndrome, Qp/Qs = ratio
of pulmonary to systemic blood flow, SCPC = superior cavopulmonary
connection, 3D = three dimensional

Summary
Patients with single ventricle physiology and greater extension and
distribution of lymphatic channels in the chest and neck at T2weighted MRI had worse outcomes after planned Fontan surgery.

Key Points
nn

nn

Two percent of patients classified with type 1 or 2 lymphatic channels (mild to moderate lymphatic distention) did not complete
Fontan palliation versus 54% of patients with type 4 (severe distention) (P , .001).
Patients classified with type 4 lymphatic channels (severe) have
greater than three times the median length of hospital stay after
Fontan surgery (29 days) in comparison to those classified with
type 1 or 2 (mild to moderate, 9 days).

evaluation with echocardiography, cardiac catheterization, and
cardiac MRI (12,13).
In this study, we hypothesized that greater neck and thoracic
lymphatic abnormalities in patients who underwent SCPC
would be associated with worse post-Fontan outcomes. Therefore, the purpose of this study was to correlate the extent of
lymphatic abnormalities at T2-weighted MRI in patients after
SCPC with surgical outcomes following the Fontan procedure.

Materials and Methods
The institutional review board at a tertiary children’s hospital
approved the study with waiver for informed consent.
Population
We performed a retrospective review of all consecutive patients
with a history of surgical palliation with SCPC who underwent
cardiac MRI with a three-dimensional (3D), T2-weighted
sampling perfection with application-optimized contrasts using different flip-angle evolution (SPACE) sequence between
June 1, 2012, and May 31, 2015, at the Children’s Hospital
of Philadelphia (Fig 1). At our institution, this T2-weighted
sequence was routinely added to the standard protocol for
cardiac MRI in all patients with single ventricle disease regardless of symptoms or indications beginning at the commencement of the study period.
MRI Protocol
All T2-weighted lymphatic imaging was performed during routine cardiac MRI examinations that were ordered for clinical indications in patients with single ventricle disease. Images were
obtained in the coronal orientation on a 1.5-T MRI magnet
(Siemens MAGNETOM Avanto, Malven, Penn) with the following parameters: matrix, 256 3 256; field of view, 300–450;
repetition time, 2500 msec; echo time, 650 msec; flip angle, 140
degrees; and voxel size, 1.0 3 1.0 3 1.0 to 1.3 3 1.3 3 1.3 mm.
All studies imaged the neck and chest. Depending on the patient’s size, the abdomen was also included as caudally as posRadiology: Volume 291: Number 3—June 2019 n radiology.rsna.org

sible. The average imaging time was approximately 5–6 minutes
but this varied based on patient size.
MRI Analysis and Classification
The T2-weighted images were evaluated independently by a pediatric radiologist (D.M.B., with 4 years of experience subspecializing in lymphatic imaging) and a pediatric interventional
cardiologist (Y.D., with 6 years of experience subspecializing
in lymphatic imaging) blinded to the clinical outcomes of the
patients. The images were reviewed in the coronal plane only
and scored on a scale of 1 to 4 based on the anatomic location
of prominent lymphatic channels within the neck and chest.
Abnormal lymphatic perfusion appears to begin with extension
of prominent lymphatic channels in the supraclavicular region
usually adjacent to the venous angle before extending to additional anatomic regions. Images at T2-weighted MRI scored
as type 1 were interpreted as having little or no presumed lymphatic channels within the supraclavicular region and mediastinum (Fig 2). Images scored as type 2 demonstrated abnormal
increased lymphatic channels within the supraclavicular region
without extension into the mediastinum (Fig 3). Images scored
as type 3 demonstrated abnormal supraclavicular lymphatics
with extension into the mediastinum (Fig 4). Images scored
as type 4 demonstrated abnormal supraclavicular lymphatic
channels with extension both into the mediastinum and in an
interstitial pattern into the lung parenchyma (Fig 5, Fig E1
[online]). Following independent evaluation of the images, discrepancies between the two readers were solved by consensus.
Data Analysis
The medical record was retrospectively reviewed. Demographic
information, including age at T2-weighted imaging, sex, age
at SCPC, and age at Fontan surgery, was obtained. The underlying cardiac anatomic and functional echocardiographic
diagnosis was also recorded. If a pre-Fontan cardiac catheterization was performed, hemodynamics including SCPC pressure, right atrial pressure, transpulmonary gradient, pulmonary
vascular resistance, and the ratio of pulmonary to systemic blood
flow (Qp/Qs) were recorded. From the Fontan operation, cardiopulmonary bypass time, cross clamp time, circulatory arrest
times, and the type of Fontan (extracardiac conduit or intraatrial lateral tunnel) were recorded.
The postoperative course following Fontan palliation was
evaluated, including Fontan completion, Fontan takedown, duration of Fontan hospitalization, duration of pleural effusion determined by duration of chest tube placement, postoperative diagnosis of plastic bronchitis, need for transplant within 3 years,
and 3-year mortality from the time of T2-weighted imaging.
Statistical Analysis
Distributions of demographic characteristics along with clinical and outcomes variables are presented by patient type.
Demographic and clinical variables include sex, age at SCPC
(continuous), age (in years) at imaging (continuous), age (in
years) at Fontan completion (continuous), dominant ventricular morphology (hypoplastic left heart syndrome [HLHS] vs
non-HLHS), ventricular dysfunction by echo (normal or mild
775
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Figure 1: Flow diagram of study cohort.

used for categorical variables. The Bonferroni correction and the Dunn test were
used for pairwise comparisons when the
overall test was statistically significant.
Statistical significance was established at
P values less than .05 for overall and pairwise adjusted tests of significance and P values less than .017 for pairwise tests that were
not adjusted. The interrater reliability of the
independent categorization of the imaging
by the two readers was measured with Fleiss
kappa coefficients. A kappa value of 0.40 or
less indicates poor agreement, 0.41–0.59
indicates fair agreement, 0.60–0.74 indicates good agreement, and 0.75 or greater
indicates excellent agreement (16). All statistical analyses were performed by using
Stata v14.0 (Stata, College Station, Tex).

Results
Patient Demographics and Clinical
History
Over 3 years, a total of 1019 cardiac MRI
examinations were performed at our institution in children and young adults.
Among these patients, 99 had undergone
an SCPC without a Fontan palliation. Although the 3D T2-weighted sequence was
included in our cardiac MRI protocol for
single ventricle disease at the commencement of the study period, 16 patients were
excluded because the 3D T2-weighted sequence was inadvertently not performed
during the cardiac examination (Fig 1). The
Figure 2: Type 1 classification schematic and T2-weighted MRI in a 39-month-old male
patient. (a) Schematic shows minimal supraclavicular increased signal intensity. (b) A
final study cohort was 83 patients (median
representative maximum intensity projection from T2-weighted MRI demonstrates minimal
age, 7.3 years [interquartile range {IQR},
lymphatic channels in the mediastinum or neck.
6.7–8.3 years]; mean age 6 standard deviation [SD], 7.9 years 6 2.6). There were 48
male patients (median age, 7.4 years [IQR, 7.0–8.3 years]; mean
vs moderate or severe), atrioventricular valve regurgitation
age 6 SD, 8.1 years 6 2.6) and 35 female patients (median
by echo (qualitatively as normal or mild, moderate, severe),
and length of Fontan operation in minutes (continuous; carage, 7.1 years [IQR, 6.1–8.3 years]; mean age 6 SD, 7.6 years
6 2.4). There was no significant difference in age distribution
diopulmonary bypass time, cross-clamp time, circulatory arbetween male and female patients (P = .124). Most of the parest times). Additional continuous clinical variables include
tients (56%) had a diagnosis of HLHS, with others presenting
cardiac catheterization: SCPC pressure (mmHg), right atrial
with various diagnoses, such as pulmonary atresia with intact
pressure (mmHg), transpulmonary gradient (mmHg), inventricular septum, double outlet right ventricle, or tricuspid
dexed pulmonary vascular resistance (Wood units), and Qp/
atresia. Among all patients, the average age at SCPC compleQs. Outcomes include Fontan completion, Fontan takedown,
tion was 0.68 years, the average age at T2-weighted imaging was
transplant within 3 years, mortality within 3 years, duration
3.3 years, and the average age at Fontan surgery (if completed)
of effusions in days, and duration of hospital stay in days. Adwas 3.6 years. None of the patients were lost to follow-up.
ditional outcomes include atrioventricular valve regurgitation
severity and a composite outcome of mortality, transplant,
Lymphatic Classification Results
Fontan takedown, and failure to achieve Fontan. Associations
Based on the imaging classification noted above (Figs 2–5),
between demographic or clinical and outcome variables were
among the 83 patients in the study, 53 (64%) were classified as
evaluated by using analysis of variance (ANOVA) and Krushaving type 1 or 2 lymphatic channels, 17 (20%) were classified
kal-Wallis H test for normally distributed and non-normally
as having type 3, and 13 (16%) were classified as having type 4.
distributed variables, respectively. The Fisher exact test was
776
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Interrater reliability was good using Fleiss kappa (κ = 0.62) and
there was no disagreement between the readers in regards to classifying type 4 patients. Demographic and clinical variables are
presented in Table 1. There was no statistical difference between
the groups in relation to the age at SCPC completion or Fontan
completion (if performed, n = 74), but there was a difference in
the age when T2-weighted imaging was performed.

tion and were significantly higher in type 4 patients (Table 2).
No significant differences among the classifications were demonstrated for the indexed pulmonary vascular resistance (reported
in 56 patients), the transpulmonary pressure gradient (reported
in 59 patients), and the Qp/Qs based on cardiac catheterization
oximetry data (reported in 55 patients) (Table 2).

Lymphatic Classification and Clinical Outcome
The associations between lymphatic classifications at MRI
and clinical outcomes are listed in Table 3. Patients with
type 1 and type 2 were grouped together since they had no
difference in clinical course and outcomes. Significant differences were demonstrated when comparing rates of Fontan
completion, 3-year mortality, duration of effusions (type 1
or 2, 6 days; type 3, 8 days; type 4, 15 days), and length of
postoperative hospital stay (type 1 or 2, 9 days; type 3, 10
days; type 4, 29 days). These significant differences were also
seen when directly cross comparing type 1 and 2 patients to
type 4 patients (Table 3). When comparing type 3 patients
to type 4 patients, a significant difference
was demonstrated in Fontan completion.
Death (n = 3), need for transplant (n =
1), extracorporeal membrane oxygenation
(ECMO ) (n = 3), plastic bronchitis (n
= 2), and acute Fontan takedown (n = 1)
were outcomes only in type 4 patients. Of
the 13 patients categorized as having type
4, only six (46%) completed the Fontan
operation and only two (15%) are alive
with Fontan anatomy at last follow-up.
On echocardiography, there was no difference between the groups in ventricular
function but type 4 patients were significantly more likely to have moderate to severe
Figure 3: Type 2 classification schematic and T2-weighted MRI in a 38-month-old female
patient. (a) Schematic depicts increased signal intensity within the bilateral supraclavicular
atrioventricular valve regurgitation compared
region without extension into the mediastinum. (b) A representative maximum intensity prowith type 1 and type 2 patients (Table 1). If
jection demonstrates increased signal intensity within bilateral supraclavicular regions more
a Fontan operation was performed (n = 74),
on the right (arrow) without extension into the mediastinum.
Lymphatic Classification and Catheterization
Outcome
Prior to Fontan completion, 61 of 83 (73%) patients underwent cardiac catheterization. All patients characterized as type
4 underwent preoperative cardiac catheterization and 15 of
17 (88%) patients categorized as type 3 underwent cardiac catheterization, whereas only 33 of 53 (62%) patients characterized
as type 1 or 2 underwent preoperative cardiac catheterization.
Table 2 lists the differences in the preoperative cardiac catheterization values and T2-weighted classification. SCPC pressures
were available in all patients who underwent cardiac catheteriza-

Figure 4: Type 3 classification schematic and T2-weighted MRI in a 34-month-old female patient. (a) Schematic demonstrates
increased signal intensity in the supraclavicular regions and extending into the mediastinum. (b) A representative maximum intensity
projection of a three-dimensional (3D), heavily T2-weighted MRI sequence demonstrates presumed lymphatic channels within the neck
with extension into the mediastinum (arrow). (c) A coronal image from a 3D, heavily T2-weighted MRI sequence better demonstrates
the extension of lymphatics within the mediastinum (arrow).
Radiology: Volume 291: Number 3—June 2019 n radiology.rsna.org
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there was no difference between the groups in regards to circulatory arrest time, cross-clamp time, or cardiopulmonary bypass
time. Additional analyses show that eight of 13 (60%) type 4
patients who had mild or moderate atrioventricular valve regurgitation experienced outcomes of death, transplant, Fontan takedown, or failure to achieve Fontan, whereas all type 4 patients
with severe atrioventricular valve regurgitation experienced one of these outcomes.

demographics and underlying cardiac anatomic categories.
However, patients with type 4 abnormality had a higher risk
for acute Fontan failure and adverse outcomes. Death (n = 3),
need for transplant (n = 1), ECMO (n = 3), plastic bronchitis
(n = 2), and need for acute Fontan takedown (n = 1) were
only present in patients within this category.

Discussion
In this study, we aimed to determine if
the grading of lymphatic abnormalities
prior to Fontan surgery correlates with
acute superior cavopulmonary connection
(SCPC) outcomes using a T2-weighted
MRI sequence. This sequence is available
across multiple vendors with different
names where a fast spin-echo sequence is
performed and optimized for isotropic 3D
imaging. We classified pre-Fontan lymphatic abnormalities into four types based
on the anatomic location of prominent
lymphatic channels within the neck and
thorax. For analysis, patients with type 1
and 2 abnormalities were grouped together
as these patients did not differ in their
clinical course and outcome. Our results
show that patients with these four types
of T2 MRI signal abnormality had similar

Figure 5: Type 4 classification schematic and T2-weighted MRI in a 7-month-old male patient. (a) Schematic shows increased abnormal signal intensity in the bilateral supraclavicular regions extending into the mediastinum and with an interstitial pattern into the lungs. (b)
A coronal image from a three-dimensional, heavily T2-weighted MRI sequence demonstrates
T2 abnormality within the bilateral supraclavicular regions with extension into the mediastinum, and into the interstitium of the lungs surrounding the right bronchus (arrow).

Table 1: Demographic and Clinical Variables in Children with SCPC with Type 1 or 2, Type 3, and Type 4 Lymphatic
Abnormalities on T2-weighted MRI

Variable
Sex
Male
Female
Age (y) at SCPC*
Age (y) at T2-weighted imaging*
Age (y) at Fontan completion, if performed*
Dominant ventricular morphology
Hypoplastic left heart syndrome
Non–hypoplastic left heart syndrome
Ventricular dysfunction echo
Normal/mild
Moderate/severe
Atrioventricular valve regurgitation by echo
Normal/mild
Moderate
Severe
Fontan operation, if performed (n = 74)*
Cardiopulmonary bypass time (min)
Cross-clamp time (min)
Circulatory arrest time (min)

Type 1 or 2 (n = 53)

Type 3 (n = 17)

Type 4 (n = 13)

P Value
.05

31 (58.5)
22 (41.5)
0.65
3.3
3.5

8 (47.1)
9 (52.9)
0.54
4.4
4.4

9 (69.2)
4 (30.8)
0.43
2.3
3.0

30 (56.6)
23 (43.4)

9 (52.9)
8 (47.1)

7 (53.8)
6 (46.2)

52 (98.1)
1 (1.9)

16 (94.1)
1 (5.9)

11 (84.6)
2 (15.4)

46 (86.8)
7 (13.2)
0 (0.0)

11 (64.7)
5 (29.4)
1 (5.9)

7 (53.8)
3 (23.1)
3 (23.1)

67.7
28.1
24.5

69.5
31.2
21.3

.07
.04
.23
.96

.12

.004

63.0
29.8
12.5

.67
.61
.06

Note.—Unless otherwise indicated, data are number of patients. Data in parentheses are percentages. SCPC = superior cavopulmonary
connection.
* Data are means.
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Table 2: Cardiac Catheterization Data and T2-weighted MRI Classification in Children with SCPC

Lymphatic Abnormality
Type 1 or 2
(n = 53)

Variable

Type 3
(n = 17)

P Value

Type 4
(n = 13)

Type 1 or 2 Type 1 or 2 Type 3 vs
All vs Type 3* vs Type 4* Type 4*

SCPC pressure (mmHg) (n = 61)
10 (9,11)
10 (8,12)
12 (11,14)
Right atrium pressure (mmHg) (n = 60)
6 (4,8)
6 (4,8)
8 (6,9)
3.8
4.1
4.5
Transpulmonary gradient (mmHg)
(n = 59)†
1.62
1.64
1.54
PVRi (Wood units) (n = 58)†
Qp/Qs (n = 55)
0.60 (0.50, 0.70) 0.65 (0.60, 0.80) 0.65 (0.53, 0.77)

.04 .94
.10 1.00
.12 NA

.02
.05
NA

.10
.16
NA

.91 NA
.33 NA

NA
NA

NA
NA

Note.—Unless otherwise indicated, data are medians. Data in parentheses are the interquartile ranges. NA = not applicable, PVRi = indexed pulmonary vascular resistance, Qp/Qs = ratio of pulmonary to systemic blood flow, SCPC = superior cavopulmonary connection.
* P values adjusted for pairwise comparison.
†
Data are means.
Table 3: Surgical Outcomes and T2-weighted MRI Classification of Neck and Thoracic Lymphatic Abnormalities in Children with Superior Cavopulmonary Connection

Lymphatic Abnormality
Surgical Outcome
Fontan completion*
Yes
No
Fontan takedown
Yes
No
Transplant*
Yes
No
Mortality*
Alive
Deceased
Duration of effusions (d)†
Duration of hospital stay (d)†

P Value

Type 1 or 2
(n = 53)

Type 3
(n = 17)

Type 4
(n = 13)

52 (98.1)
1 (1.9)

16 (94.1)
1 (5.9)

6 (46.2)
7 (53.8)

0 (0.0)
53 (100)

0 (0.0)
17 (100)

1 (7.7)
12 (92.3)

0 (0.0)
53 (100)

0 (0.0)
17 (100)

1 (7.7)
12 (92.3)

53 (100)
0 (0.0)
6 (4, 8.5)
9 (7, 11)

17 (100)
0 (0.0)
8 (6.5,17)
10 (8, 34)

10 (76.9)
3 (23.1)
14.5 (9.5, 20)
28.5 (21.5, 29.5)

All

Type 1 or 2
vs Type 3

Type 1 or 2
vs Type 4

Type 3 vs
Type 4

,.01

.43

,.001

.01

.07

NA

NA

NA

.16

NA

.20

.43

.003 NA

.006

.07

.02 .11
.003 .07

.03
.003

.29
.10

Note.—Unless otherwise indicated, data are number of patients. Data in parentheses are percentages. NA = not applicable.
* P value level of significance for pairwise comparisons = .017.
†
Data are medians. Data in parentheses are first and third quartiles. P values adjusted for pairwise comparison.

Previously, we have demonstrated by dynamic contrast material–enhanced MR lymphangiography that the reticulated supraclavicular, mediastinal, peribronchial, and pulmonary interstitial findings correlate with abnormal lymphatic perfusion and
dilated lymphatic networks (3,4). When extending into the lung
parenchyma, as seen in type 4 patients, this abnormal perfusion has been called pulmonary lymphatic perfusion syndrome
(4). Patients with type 3 and type 4 imaging findings appear to
be clinically distinct, with patients with type 4 findings having
poorer outcomes. However, it is unclear if these categories represent distinctly different congenital lymphatic abnormalities or
whether these represent the severe end of a spectrum of the same
abnormality. It is possible that the distinction between these categories is a result of varying progression of the same abnormality
as a result of chronic lymphatic overload in the setting of chronically increased central venous pressure.
Radiology: Volume 291: Number 3—June 2019 n radiology.rsna.org

Several studies have shown that lymphatic abnormalities in
patients with single ventricle anatomy can be present prenatally,
possibly pointing toward a congenital etiology (11,17,18). It has
also been shown that prenatal abnormalities correlate with poor
neonatal outcome (11). Furthermore, it is known that increased
innominate vein pressure inherent in SCPC physiology leads
to increased lymphatic afterload and poor lymphatic drainage,
perhaps supporting lymphatic overload as a potential etiology
(9,19). Upon conversion to Fontan physiology, elevated central
venous pressure leads to significant increased lymphatic production mainly by the liver, which could lead to early lymphatic failure and possibly Fontan failure; this explains why patients with
severe pre-Fontan lymphatic abnormalities do not do well after
the Fontan operation. It seems most likely that a combination of
anatomic susceptibility with increased load is the etiology of the
abnormalities described here.
779
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Given the high mortality rate and Fontan failure rate in the
type 4 patients, it would be beneficial to try to identify patient
characteristics in this group that put these patients at risk for
acute Fontan catastrophic events such as need for transplant,
ECMO, Fontan takedown, or death. Of the five patients who
died (three within 3 years), three had poor SCPC hemodynamics with SCPC pressures above 15 mmHg, three had severe valve
regurgitation, and two had severe ventricular dysfunction. This
would suggest that patients with lymphatic dysfunction combined with poor hemodynamics or cardiac function are at particularly high risk. New lymphatic interventional techniques
could potentially alter the outcome of these patients but further
studies will need to be conducted to better understand which of
the patients with severe lymphatic abnormalities will ultimately
be able to complete the Fontan operation successfully and which
should be considered for transplant as an alternative strategy.
The main limitation of this study is that it is retrospective. In
addition, there is a risk for selection bias as only patients referred
for pre-Fontan cardiac MRI were included and they may not be
representative of the entire Fontan population. Despite there being a possible selection bias in the patients chosen for MRI studies,
this percentage of patients is consistent with the rate of acute Fontan failure reported in the literature when pleural effusions were
considered as a criteria for acute Fontan failure (13). Although
there was moderate interrater reliability, additional standardization with further experience may be beneficial. The follow-up of
our cohort is also relatively short term; adverse outcomes such as
plastic bronchitis, cardiac transplant, and mortality are time-dependent and would be influenced with a longer-term follow-up.
This study demonstrates an association between lymphatic
abnormality grading on T2-weighted imaging and Fontan outcomes. Grading of lymphatic patterns on T2-weighted MRI
may serve as a noninvasive means of risk assessment prior to
Fontan sugery and warrants further investigation.
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